Doug Lozier Doug Lozier

Demand for cGMP manufacturing space—or pharmaceutical drug manufacturing space—is growing, thanks to new drug applications and FDA drug approvals. In San Diego, which is a significant hub for cGMP users—the new demand is causing a supply shortage in an already very tight industrial market. While industrial users in general are finding the market challenging, the specialized requirements and large capital investment needed for cGMP spaces put additional pressure on this niche of users. We sat down with Doug Lozier, SVP at CBRE and an expert in this space, for an exclusive interview to talk about the demand for cGMP space and how users are coping with the supply.